Market Cap 3.85B
Revenue (ttm) 806.78M
Net Income (ttm) -363.30M
EPS (ttm) N/A
PE Ratio 6.74
Forward PE 6.21
Profit Margin -45.03%
Debt to Equity Ratio -12.83
Volume 1,170,800
Avg Vol 1,318,330
Day's Range N/A - N/A
Shares Out 79.26M
Stochastic %K 84%
Beta 0.52
Analysts Strong Sell
Price Target $61.67

Latest News on PTCT

PTC Therapeutics, Inc. (PTCT) Q1 2025 Earnings Call Transcript

May 6, 2025, 11:19 PM EDT - 4 weeks ago

PTC Therapeutics, Inc. (PTCT) Q1 2025 Earnings Call Transcript


PTC518 PIVOT-HD Study Achieves Primary Endpoint

May 5, 2025, 7:00 AM EDT - 4 weeks ago

PTC518 PIVOT-HD Study Achieves Primary Endpoint


Vaccine stocks fall following FDA resignation

Mar 31, 2025, 6:21 PM EDT - 2 months ago

Vaccine stocks fall following FDA resignation

BNTX MRNA NVAX PFE PCVX XBI


PTC Therapeutics: Upside In Rare Disease Innovation

Mar 9, 2025, 9:47 AM EDT - 3 months ago

PTC Therapeutics: Upside In Rare Disease Innovation


PTC Therapeutics, Inc. (PTCT) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 9:41 PM EST - 3 months ago

PTC Therapeutics, Inc. (PTCT) Q4 2024 Earnings Call Transcript


PTC Therapeutics to Participate in Upcoming Investor Conferences

Feb 20, 2025, 8:00 AM EST - 3 months ago

PTC Therapeutics to Participate in Upcoming Investor Conferences